Nomura Holdings
CLDX icon

Nomura Holdings’s Celldex Therapeutics CLDX Stock Holding History

Nomura Holdings’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-3,427
Closed -$834K – 2793
2014
Q2 		$834K Buy
+3,427
New +$774K ﹤0.01% 1521
2014
Q1 		– Sell
-1,721
Closed -$625K – 2741
2013
Q4 		$625K Sell
1,721
-284
-14% -$109K ﹤0.01% 1183
2013
Q3 		$1.06M Sell
2,005
-60
-3% -$20.6K 0.01% 1055
2013
Q2 		$482K Buy
+2,065
New +$407K ﹤0.01% 1347

Other funds holding CLDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Nomura Holdings's CLDX Position: Q3 2014 in Review

Nomura Holdings sold out of Celldex Therapeutics (CLDX) in Q3 2014, closing a stake of 3,427 shares — an estimated $834K sold.

Nomura Holdings first reported a position in CLDX in Q2 2013 and held it in 4 quarters. The position peaked at $1.06M in Q3 2013. 148 funds tracked by Wall St. Rank hold CLDX as of Q3 2014.

  • Nomura Holdings reported no remaining Celldex Therapeutics position as of Q3 2014 after selling out during the quarter.
  • Nomura Holdings sold 3,427 Celldex Therapeutics shares in Q3 2014, an estimated $834K.
  • Nomura Holdings first reported a position in Celldex Therapeutics in Q2 2013 and held it in 4 quarters.
  • Nomura Holdings's Celldex Therapeutics position peaked at $1.06M in Q3 2013.
  • 148 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q3 2014.

Based on Nomura Holdings's 13F filing for Q3 2014, filed 14 Nov 2014.